Welcome to our dedicated page for The Carlyle Group SEC filings (Ticker: CG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Carlyle Group's SEC filings reveal the operational and financial dynamics of one of the world's largest alternative asset managers. Unlike traditional corporations, Carlyle's 10-Q quarterly reports and 10-K annual filings detail unique metrics including assets under management by segment, fee-related earnings versus performance-based earnings, unrealized carried interest, and the composition of its investment portfolio across private equity, credit, and real assets. These disclosures help investors understand how the business generates revenue from both management fees and performance-based compensation tied to investment gains.
Carlyle's 13F-HR filings provide quarterly snapshots of the firm's publicly traded equity holdings, offering visibility into which stocks the firm's liquid credit and public equity strategies are accumulating or reducing. While private equity represents Carlyle's core business, these public holdings disclosures reveal how the firm's registered investment companies and credit vehicles position themselves in public markets. Our AI summaries highlight significant portfolio changes and concentration shifts across sectors.
Form 4 filings track insider transactions by Carlyle's executives and board members, showing when leadership buys or sells CG units. These transactions can signal confidence in the firm's growth prospects or simply reflect portfolio rebalancing and compensation-related activity. Monitoring insider trading patterns provides context on management's perspective, particularly around earnings releases or major strategic announcements.
The firm's 8-K filings disclose material events including significant fund closings, major acquisitions or dispositions, changes in governance structure, or developments affecting the partnership's traded units. For a firm operating across dozens of investment funds with varying life cycles, these event-driven disclosures help investors track meaningful changes in Carlyle's investment activities and corporate structure. Form DEF 14A proxy statements reveal executive compensation structures, governance arrangements, and proposals requiring unitholder votes, offering transparency into how performance-based pay aligns management incentives with investment returns.
The Carlyle Group Inc. reports its beneficial ownership in Medline Inc. (MDLN) as a director and more than 10% owner. Through affiliated investment vehicles, it indirectly holds 158,245,640 shares of Medline Class A common stock and 77,742,972 shares of Class B common stock.
The filing explains that each share of Medline Class B common stock has one vote but no economic value, and is paired with one common unit of Medline Holdings, LP. Under a December 16, 2025 exchange agreement, holders may exchange these 77,742,972 common units for an equal number of Medline Class A shares on a one-for-one basis, with exchange rights that do not expire. When units are exchanged, the same number of Class B shares are automatically cancelled.
Carlyle Group Inc. reported an insider transaction by its Chief Executive Officer and director, Harvey M. Schwartz, related to equity compensation. On 12/15/2025, 310,696 shares of common stock were withheld by the company at a price of $58.35 per share to cover taxes due on the vesting of a previously reported restricted stock unit award. The filing states that no shares of common stock were sold by the reporting person in this transaction. Following the tax withholding, Schwartz beneficially owns 5,929,596 shares of Carlyle common stock in direct ownership.
Carlyle Group Inc. director David M. Rubenstein reported major share movements dated December 10, 2025. He made a charitable gift of 625,000 shares of Carlyle common stock, reported at a price of $0, and separately sold another 625,000 shares at $56.55 per share.
After these transactions, Rubenstein directly beneficially owned 27,999,644 shares of Carlyle common stock. The activity is reported on a Form 4 for one reporting person in his role as a director of Carlyle Group Inc.
Carlyle Group Inc. director reports charitable stock gifts. Director Anthony S. Welters filed a Form 4 showing two charitable donations of Carlyle common stock on 11/25/2025. One transaction transferred 11,706 shares at a reported price of $0, and a second transaction transferred 1,200 shares at a reported price of $0, each coded as a gift. After these transactions, Welters directly beneficially owned 43,399 shares of Carlyle common stock.
Carlyle Group Inc. (CG) reported an insider equity transaction involving its Chief Executive Officer and director, Harvey M. Schwartz. On 11/19/2025, Schwartz acquired 28,519 shares of common stock at a price of $0, bringing his total beneficial ownership to 6,240,292 shares held directly.
The new shares represent dividend equivalent units that accrued on existing time-based and performance-based restricted stock unit awards originally granted on February 15, 2023, in connection with Carlyle’s quarterly dividend. These dividend equivalent units will vest on the same schedule and under the same terms and conditions as the underlying restricted stock unit awards.
Carlyle Group Inc. (CG) filed a Form 4 reporting a routine equity award to its Chief Financial Officer. On 11/19/2025, the CFO acquired 3,730 shares of common stock at a price of $0. These shares are dividend equivalent units accrued on previously granted time-vesting restricted stock unit awards in connection with Carlyle’s quarterly dividend and will vest on the same schedule and terms as the underlying awards.
Following this transaction, the CFO beneficially owns 1,100,116 shares of Carlyle Group Inc. common stock in direct ownership form. The filing does not report any sales or derivative security activity, only the incremental dividend-related units tied to existing equity awards.
Carlyle Group Inc. (CG) Chief Operating Officer Lindsay LoBue reported an automatic equity accrual tied to the company’s regular dividend. On 11/19/2025, LoBue received 620 shares of common stock as dividend equivalent units at a price of $0, reflecting additional units credited on previously granted time-vesting restricted stock unit awards. These dividend equivalent units vest on the same schedule and under the same conditions as the original awards. Following this transaction, LoBue beneficially owned 476,845 shares of Carlyle common stock in direct ownership.
Carlyle Group Inc. (CG) reported a routine insider equity change for its General Counsel, Jeffrey W. Ferguson. On 11/19/2025, Ferguson acquired 928 shares of common stock at a price of $0. These were recorded as dividend equivalent units credited on previously granted time-vesting restricted stock unit awards in connection with the company’s quarterly dividend.
After this transaction, Ferguson beneficially owns 754,927 shares of Carlyle Group Inc. common stock in direct ownership. The newly credited dividend equivalent units will vest on the same schedule and under the same terms and conditions as the underlying restricted stock unit awards.
Carlyle Group Inc. (CG) reported a routine insider equity transaction involving its Chief Accounting Officer. On 11/19/2025, the officer acquired 220 shares of common stock at a stated price of $0, classified as an acquisition. After this transaction, the officer beneficially owned 131,174 shares of Carlyle Group common stock in direct ownership.
According to the explanation, the 220 units represent dividend equivalent units that accrued on previously granted time-vesting restricted stock unit awards in connection with Carlyle’s quarterly dividend. These dividend equivalent units will vest on the same schedule and under the same terms and conditions as the underlying restricted stock unit awards, so they track the timing and risk profile of the existing equity grants.
FAQ
What is the current stock price of The Carlyle Group (CG)?
What is the market cap of The Carlyle Group (CG)?
